New drug TAKHZYRO tracked for Long-Term safety in rare swelling disorder
NCT ID NCT05397431
First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 3 times
Summary
This study follows 155 people in Japan with hereditary angioedema (HAE) who are taking TAKHZYRO (lanadelumab) injections every two weeks. Researchers will monitor side effects and check if the drug helps control swelling attacks over 12 months. The goal is to see how well TAKHZYRO works in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lanadelumab (TAKHZYRO)
- What this could lead to
- If successful, this study could confirm that TAKHZYRO is safe and effective for long-term use in controlling HAE attacks.
- What could go wrong
- This is an observational survey, not a controlled trial, so results may be less definitive. Side effects are still possible, and the study only includes Japanese participants, so findings may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Takeda selected site
Tokyo, Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- HAE patients and caregivers speak out: the hidden costs of On-Demand treatment
- Real-world study shows lanadelumab keeps HAE attacks at bay for many patients
- Takhzyro under the microscope: Real-World safety check for rare swelling disease
- New hope for HAE patients: experimental drug aims to slash attack rate
- New RNA drug shows promise in preventing HAE attacks in ongoing study
- New shot could stop painful swelling attacks in kids